Value of microsatellite instability typing in detecting hereditary non-polyposis colorectal cancer

Gastroenterologie Clinique et Biologique

Volumn 29, Issue 6-7, 2005, Pages 667-675

  Bécouarn, Yves ^a   Rullier, Anne ^b   Gorry, Philippe ^b   Smith, Denis ^c   Richard Molard, Bruno ^d   Echinard, Emmanuel ^e   Texereau, Patrick ^f   Beyssac, Richard ^g   Legoux, Jean Louis ^h   Lamouliatte, Hervé ^c   Frebourg, Thierry ⁱ   Olschwang, Sylviane ^j   Gilbert, Brigitte ^k   Venat, Laurence ^l   Picot, Véronique ^a   Paraf, François ^l   Longy, Michel ^a  

^a INSTITUT BERGONIÉ   (France)

^b HÔPITAL PELLEGRIN   (France)

^c HÔPITAL SAINT ANDRÉ   (France)

^d Polyclinique Bordeaux Nord   (France)

^e Clinique Saint Etienne et du Pays Basque   (France)

^f CENTRE HOSPITALIER   (France)

^g Maison de santé protestante de Bordeaux Bagatelle   (France)

^h HAUT LÉVÊQUE HOSPITAL   (France)

ⁱ ROUEN UNIVERSITY HOSPITAL   (France)

^j FONDATION JEAN DAUSSET CEPH   (France)

^k University of Poitiers   (France)

^l DUPUYTREN UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER DIAGNOSIS; CHILD; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MULTICENTER STUDY; NEWBORN; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

EID: 21844432944     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(05)82155-4     Document Type: Article

References (55)

1. Conférence de consensus. Prévention, dépistage et prise en charge des cancers du côlon. Gastroenterol Clin Biol 1998;22:205-26.
2. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998;338:1481-7.
3. Grandjouan S. Surveillance des sujets à risque très élevé de cancer colorectal (polyposes, cancer colique héréditaire sans polypose). Acta Endoscopica 2002;32:633-64.
4. Frebourg T, Mauillon J, Thomas G, Olschwang S. Le cancer colorectal héréditaire non polyposique. Définition, génétique, diagnostic et surveillance médicale. Gastroenterol Clin Biol 2003;27:708-14.
5. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-38.
6. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-25.
7. Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, et al. Mutation of a mutL homolog in hereditary colon cancer. Science 1994;263:1625-9.
8. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994;368:258-61.
9. Jarvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995;108:1405-11.
10. Syngal S, Weeks JC, Schrag D, Garber JE, Kuntz KM. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med 1998;129:787-96.
11. Vasen HF, van Ballegooijen M, Buskens E, Kleibeuker JK, Taal BG, Griffioen G, et al. A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer 1998;82:1632-7.
12. Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000;118:829-34.
13. Vasen HF. Clinical diagnosis and management of hereditary colorectal cancer syndromes. J Clin Oncol 2000;18:81S-92S.
14. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HN-PCC. Gastroenterology 1999;116:1453-6.
15. Syngal S. Hereditary nonpolyposis colorectal cancer: a call for attention. J Clin Oncol 2000;18:2189-92.
16. de la Chapelle A. Microsatellite instability phenotype of tumors: genotyping or immunohistochemistry? The jury is still out. J Clin Oncol 2002;20:897-9.
17. Thomas HJ. Genetic instability in colorectal cancer. Gut 1998; 43:450-1.
18. Salovaara R, Loukola A, Kristo P, Kaariainen H, Ahtola H, Eskelinen M, et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 2000;18:2193-200.
19. Terdiman JP, Gum JR, Jr., Conrad PG, Miller GA, Weinberg V, Crawley SC, et al. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology 2001; 120:21-30.
20. Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, Sargent DJ, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002;20: 1043-8.
21. de la Chapelle A. Microsatellite instability. N Engl J Med 2003;349: 209-10.
22. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997;57:808-11.
23. Cunningham JM, Kim CY, Christensen ER, Tester DJ, Pare Y, Burgart LJ, et al. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet 2001;69:780-90.
24. Marcus VA, Madlensky L, Gryte R, Kim H, So K, Millar A, et al. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 1999; 23:1248-55.
25. Chaves P, Cruz C, Lage P. Claro I, Cravo M, Leitao CN, et al. Immunohistochemical detection of mismatch repair gene proteins as a useful tool for the identification of colorectal carcinoma with the mutator phenotype. J Pathol 2000;191:355-60.
26. Longy M, Duboue B, Soubeyran P, Moynet D. Method for the purification of tissue DNA suitable for PCR after fixation with Bouin's fluid. Uses and limitations in microsatellite typing. Diagn Mol Pathol 1997;6:167-73.
27. Paraf F, Gilquin M, Longy M, Gilbert B, Gorry P, Petit B, et al. MLH1 and MSH2 protein immunohistochemistry is useful for detection of hereditary non-polyposis colorectal cancer in young patients. Histopathology 2001;39:250-8.
28. Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW, et al. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 1995;55:5548-50.
29. Makela TP, Hellsten E, Vesa J, Alitalo K, Peltonen L. An Alu variable polyA repeat polymorphism upstream of L-myc at 1p32. Hum Mol Genet 1992;1:217.
30. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, et al. The 1993-94 Genethon human genetic linkage map. Nat Genet 1994;7:246-339.
31. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
32. Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R, Ruschoff J. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 1997; 57:4749-56.
33. Dieumegard B, Grandjouan S, Sabourin JC, Le Bihan ML, Lefrere J, Bellefqih, et al. Extensive molecular screening for hereditary non-polyposis colorectal cancer. Br J Cancer 2000;82:871-80.
34. Debniak T, Kurzawski G, Gorski B, Kladny J, Domagala W, Lubinski J. Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer. Eur J Cancer 2000;36:49-54.
35. Parc Y, Boisson C, Thomas G, Olschwang S. Cancer risk in 348 French MSH2 or MLH1 gene carriers. J Med Genet 2003;40:208-13.
36. Charbonnier F, Raux G, Wang Q, Drouot N, Cordier F, Limacher JM, et al. Detection of exon deletions and duplications of the mismatch re-pair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments. Cancer Res 2000;60:2760-3.
37. Samowitz WS, Slattery ML, Kerber RA. Microsatellite instability in human colonie cancer is not a useful clinical indicator of familial colorectal cancer. Gastroenterology 1995;109:1765-71.
38. Brown SR, Finan PJ, Cawkwell L, Quirke P, Bishop DT. Frequency of replication errors in colorectal cancer and their association with family history. Gut 1998;43:553-7.
39. Cawkwell L, Gray S, Murgatroyd H, Sutherland F, Haine L, Longfellow M, et al. Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut 1999;45:409-15.
40. Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994;145:148-56.
41. Percesepe A, Borghi F, Menigatti M, Losi L, Foroni M, Di Gregorio C, et al. Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study. J Clin Oncol 2001;19: 3944-50.
42. Ward R, Meagher A, Tomlinson I, O'Connor T, Norrie M, Wu R, et al. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut 2001;48:821-9.
43. Wijnen JT, Vasen HF, Khan PM, Zwinderman AH, van der KH, Mulder A, et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 1998; 339:511-8.
44. Wu Y, Berends MJ, Mensink RG, Kempinga C, Sijmons RH. Der Zee AG, et al. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet 1999;65:1291-8.
45. Charbonnier F, Olschwang S, Wang Q, Boisson C, Martin C, Buisine MP, et al. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer. Cancer Res 2002;62:848-53.
46. Wijnen J, de Leeuw W, Vasen H, van der KH, Moller P, Stormorken A, et al. Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 1999;23:142-4.
47. Huang J, Kuismanen SA, Liu T, Chadwick RB, Johnson CK, Stevens MW, et al. MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer. Cancer Res 2001;61: 1619-23.
48. Berends MJ, Wu Y, Sijmons RH, Mensink RG, van der ST, Hordijk-Hos JM, et al. Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. Am J Hum Genet 2002;70:26-37.
49. Wu Y, Berends MJ, Sijmons RH, Mensink RG, Verlind E, Kooi KA, et al. A role for MLH3 in hereditary nonpolyposis colorectal cancer. Nat Genet 2001;29:137-8.
50. Liu T, Yan H, Kuismanen S, Percesepe A, Bisgaard ML, Pedroni M. et al. The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res 2001;61:7798-802.
51. Liu B, Farrington SM, Petersen GM, Hamilton SR, Parsons R, Papadopoulos N, et al. Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med 1995;1:348-52.
52. Farrington SM, Lin-Goerke J, Ling J, Wang Y, Burczak JD, Robbins DJ, et al. Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls. Am J Hum Genet 1998;63: 749-59.
53. Liu T, Tannergard P, Hackman P, Rubio C, Kressner U, Lindmark G, et al. Missense mutations in hMLH1 associated with colorectal cancer. Hum Genet 1999;105:437-41.
54. Scartozzi M, Bianchi F, Rosati S, Galizia E, Antolini A, Loretelli C, et al. Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression. J Clin Oncol 2002;20:1203-8.
55. Olschwang S, Bonaiti C, Feingold J, Frebourg T, Grandjouan S, Lasset C, et al. Identification et prise en charge du syndrome HNPCC (hereditary non polyposis colon cancer), Prédisposition héréditaire aux cancers du côlon, du rectum et de l'utérus. Bull Cancer 2004;91: 303-15.